Skip to: Content
Skip to: Site Navigation
Skip to: Search
THURSDAY, NOVEMBER 26, 2009
| Subscribe to Newser's RSS feeds RSS | Follow Newser on Twitter Twitter

NEWS ABOUT: diabetes

diabetes stories: 73 news summaries

61 - 73 of 73 Stories | << Prev 1 2 3 4

Switch to grid view »

Weight-Loss Surgery Can
End Diabetes

Intestinal rerouting works miracles, but science still debated

Aug 22, 07 10:52 AM CDT
(Newser) - Surgery that shrinks stomachs and reroutes intestines can make diabetes disappear—but some worry the procedure is the wrong one for the disease. More than three of four diabetics who undergo bariatric surgery are left with no symptoms, and can even live without insulin. But docs are concerned about complications... More »

MORE ABOUT:
obesity • health • surgery • diabetes • bariatric surgery • insulin • intestines

New Procedure Gives Hope to Diabetics

UK treatment ends insulin dependency for type 1 sufferers

Aug 19, 07 5:55 PM CDT
(Newser) - Car crashes, comas, sudden stabbings, divorces – all are being indirectly diminished as Britain spearheads a new procedure to help sufferers of type 1 diabetes. Victims of the growing disorder are often subject to fits and blackouts as they scramble for insulin, but a new operation is offering hope: already... More »

MORE ABOUT:
medicine • medical breakthrough • health • diabetes • disease • United Kingdom • Islet cell transplantation • diabetics • pancreas • liver

Bone Hormone Could Help Treat Diabetes

Bones produce a hormone that controls blood sugar

Aug 13, 07 3:08 PM CDT
(Newser) - A substance produced by the skeleton may help to treat diabetes, a new study suggests. A hormone called osteocalcin regulates blood sugar; type 2 diabetics have a lower level of the hormone than other people. In the study, mice with lower levels of osteocalcin develop symptoms of diabetes, which go... More »

MORE ABOUT:
health • diabetes • hormones • treatment • osteocalcin • skeleton • bones • blood sugar

FDA Panel Votes to Keep Avandia on Shelves

Controversial diabetes drug still faces heart-attack link

Jul 30, 07 5:38 PM CDT
(Newser) - An FDA panel said today that GlaxoSmithKline's diabetes drug Avandia should remain in drugstores, despite earlier evidence the pill ups heart failure risks. Glaxo has defended its drug, countering that the risks associated with the popular Avandia are the same as those of other diabetes drugs. More »

MORE ABOUT:
FDA • health • drugs • diabetes • GlaxoSmithKline • Avandia • safety • heart failure

Coffee's Perks Not in the Caffeine

Go for decaf: other chemicals in coffee
give health a jolt

Jun 25, 07 3:59 AM CDT
(Newser) - Scientists have long championed coffee's health benefits, but a series of recent studies is waking them up to the fact that caffeine has nothing to do with it. Regular consumption of coffee or tea can provide protection against cancer, diabetes and heart disease, but researchers say other chemicals are responsible. More »

MORE ABOUT:
cancer • health • diabetes • coffee • science • heart disease • caffeine • tea • stress • antioxidants

Genes Give Up Secrets of 7 Serious Diseases

Landmark study sheds light on diabetes, depression, more

Jun 7, 07 8:18 AM CDT
(Newser) - In an outcome one scientist describes as a "new dawn," researchers have identified genetic variations linked to seven common diseases, opening the door to improved tests and treatments. The study, which focused on depression, Crohn's disease, coronary artery disease, hypertension, rheumatoid arthritis, and Type 1 and 2 diabetes,... More »

MORE ABOUT:
medicine • health • hypertension • depression • genetics • diabetes • disease • heart disease • rheumatoid arthritis • Crohn's disease

Controversy Rages Over Diabetes Drug's Heart Risks

FDA official says superiors ordered her to back off serious warning

Jun 6, 07 12:16 PM CDT
(Newser) - Troubling questions about the diabetes drug Avandia persisted yesterday as an FDA official revealed that she was barred from recommending a critical warning about the medication, the Times reports. In the run-up to congressional hearings that began today, manufacturer GlaxoSmithKline rushed to disseminate interim clinical findings in hopes of blunting... More »

MORE ABOUT:
medicine • FDA • health • diabetes • GlaxoSmithKline • Avandia • heart • heart attack

Glaxo Stems Stock Slide
Over Avandia

Medical chief rebuts findings on heart risks; claims comparable to other drugs

May 31, 07 6:44 AM CDT
(Newser) - Glaxo shares pulled out of a tailspin after the pharma giant defended its second biggest selling drug, Avandia, against claims that it triggers heart attacks.  A sharply worded letter from the company's chief medical officer on the website of medical journal The Lancet pointed out that the increased incidence... More »

MORE ABOUT:
medicine • drugs • diabetes • GlaxoSmithKline • Avandia • pharma • heart attack

FDA Warned of Avandia Risks Years Ago

Doctor alerted agency to cardiovascular concerns in 2000

May 24, 07 1:56 PM CDT
(Newser) - A diabetes doctor warned the FDA of heart risks posed by the diabetes drug Avandia seven years ago, the New York Times reports. The same concerns raised by Dr. John Buse in a 2000 letter were reiterated in a study published by cardiologist Steven Nissen this week. More »

MORE ABOUT:
health • diabetes • GlaxoSmithKline • Avandia • pharma • John Buse

Drug Company Nemesis
Strikes Again

Crusading cardiologist took on Vioxx, now Avandia, for heart risks

May 22, 07 1:32 PM CDT
(Newser) - The doctor who helped to raise concerns about the painkiller Vioxx is back—with the study released earlier this week linking the same company's popular diabetes drug, Avandia, to higher risk of heart attacks. The Wall Street Journal looks at 58-year-old cardiologist Steven Nissen's role in identifying and publicizing drug... More »

MORE ABOUT:
medicine • FDA • drugs • diabetes • pharmaceutical companies • GlaxoSmithKline • Avandia • Steven Nissen • Vioxx

Diabetes
Drug Ups
Heart Risk

New study documents dangers of Avandia, but company nixes recall

May 21, 07 3:15 PM CDT
(Newser) - A popular diabetes drug may increase heart attack risks, a study reported in the New England Journal of Medicine concludes. Patients who took Avandia, which treats Type 2 diabetes, were 43% more likely to have a heart attack than those who took a placebo, the Cleveland Clinic study found. More »

MORE ABOUT:
medicine • FDA • health • diabetes • pharmaceutical companies • GlaxoSmithKline • Avandia • pharma • medical research • heart attack

Researchers Fight Fat With Baby Formula

Introducing hormone in infancy
trims down rats, sparks controversy

Apr 23, 07 3:18 PM CDT
(Newser) - The battle to keep pounds off may start with a baby bottle, say a team of British scientists who found that feeding large doses of the appetite-controlling hormone leptin to baby rats led to svelte adult rats. If those results translate to humans, a baby formula that chemically alters metabolism... More »

MORE ABOUT:
obesity • health • childhood obesity • diabetes • leptin • children • research • baby

Insurer Ties Employee Pay to Patient Health

Plan will offer bonuses for boosting patients' use of preventive services

Apr 4, 07 8:32 AM CDT
(Newser) - The country's largest health insurer says it will pay up for good health--offering bonuses to employees who boost patients' use of preventive medical services. WellPoint Inc.'s plan is intended to encourage participation in programs like diabetes management, which helps patients handle their medical needs before they end up in... More »

MORE ABOUT:
medicine • health care • health care costs • health • health insurance • insurance companies • preventative medicine • WellPoint Inc. • diabetes • insurance

61 - 73 of 73 Stories | << Prev 1 2 3 4


from our news partners